Compare Enveric Biosciences Inc (ENVB) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Sunrun Inc — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while Sunrun Inc trades at $12.11 (market cap $3.05B). The key difference: Sunrun Inc is far larger — about 573.3× Enveric Biosciences Inc's market cap, and Sunrun Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | RUN | |
|---|---|---|
Market Cap | $5.32M | $3.05B |
Sector | Health | Technology |
52-Week High | $17.40 | $21.41 |
52-Week Low | $1.28 | $9.07 |
Enterprise Value | $408.82K | $17.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Sunrun (RUN) trades at $12.13, down 5.09% over 24 hours, with a bearish technical signal from moving averages. The company shows strong profitability with a 17.88% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights a major partnership with Tesla and Renew Home to create a 16-gigawatt virtual power plant, positioning the company to capitalize on AI data center power demand.
The outlook is mixed; analyst consensus is bullish with a $16.27 price target, but negative operating cash flow and high debt-to-asset ratio of 70.76% pose risks. Upside depends on successful execution of new initiatives and improved cash generation, while volatility may persist amid market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
